Human TRAILR1/TNFRSF10A Biotinylated Antibody
R&D Systems, part of Bio-Techne | Catalog # BAF347
Key Product Details
Species Reactivity
Validated:
Cited:
Applications
Validated:
Cited:
Label
Antibody Source
Product Specifications
Immunogen
Ala24-Asn239
Accession # AAC51226
Specificity
Clonality
Host
Isotype
Applications for Human TRAILR1/TNFRSF10A Biotinylated Antibody
Western Blot
Sample: Recombinant Human TRAIL R1/TNFRSF10A Fc Chimera (Catalog # 347-DR)
Formulation, Preparation, and Storage
Purification
Reconstitution
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: TRAILR1/TNFRSF10A
Human TRAIL R1, also called DR4, is a type 1, TNF R family, membrane protein which is a receptor for TRAIL (APO2 ligand). In the TNF superfamily nomenclature, TRAIL RI is referred to as TNFRSF10A. TRAIL R1 cDNA encodes a 468 amino acid residue precursor protein containing extracellular cysteine-rich domains, a transmembrane domain and a cytoplasmic death domain. Among the TNF receptor family proteins, TRAIL R1 is most closely related to TRAIL R2/DR5, sharing 55% amino acid sequence identity. Binding of trimeric TRAIL to TRAIL R1 induces apoptosis. The induction of apoptosis likely requires oligomerization of the receptor. The human TRAIL R1/Fc chimera neutralizes the ability of TRAIL to induce apoptosis. Besides TRAIL R1, an additional TRAIL R2/DR5, which tranduces apoptosis signal, and two TRAIL decoy receptors, which antagonize TRAIL-induced apoptosis, have been reported.
References
- Pan, G. et al. (1997) Science 276:111.
- Golstein, P. (1997) Curr. Biol. 7:R750.
Long Name
Alternate Names
Entrez Gene IDs
Gene Symbol
UniProt
Additional TRAILR1/TNFRSF10A Products
Product Documents for Human TRAILR1/TNFRSF10A Biotinylated Antibody
Product Specific Notices for Human TRAILR1/TNFRSF10A Biotinylated Antibody
For research use only